• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙二胺二乙酸(EDDA)介导的超声条件下奥rone 的合成:作为 SIRT1 抑制剂的评价。

Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.

机构信息

Institute of Life Sciences, University of Hyderabad Campus, Hyderabad 500 046, India.

出版信息

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6160-5. doi: 10.1016/j.bmcl.2012.08.017. Epub 2012 Aug 9.

DOI:10.1016/j.bmcl.2012.08.017
PMID:22929231
Abstract

An improved synthesis of functionalized aurones has been accomplished via the reaction of benzofuran-3(2H)-one with a range of benzaldehydes in the presence of a mild base EDDA under ultrasound. A number of aurones were synthesized (within 5-30min) and the molecular structure of a representative compound determined by single crystal X-ray diffraction study confirmed Z-geometry of the C-C double bond present within the molecule. Some of the compounds synthesized have shown SIRT1 inhibiting as well as anti proliferative properties against two cancer cell lines in vitro. Compound 3a [(Z)-2-(5-bromo-2-hydroxybenzylidene) benzofuran-3(2H)-one] was identified as a potent inhibitor of SIRT1 (IC(50)=1μM) which showed a dose dependent increase in the acetylation of p53 resulting in induction of apoptosis.

摘要

通过在超声条件下,用温和的碱 EDDA 使苯并呋喃-3(2H)-酮与一系列苯甲醛反应,实现了功能化奥酮的改进合成。合成了许多奥酮(5-30 分钟内),并通过单晶 X 射线衍射研究确定了一个代表性化合物的分子结构,证实了分子中存在的 C-C 双键的 Z-几何构型。一些合成的化合物已显示出对两种体外癌细胞系的 SIRT1 抑制作用和抗增殖特性。化合物 3a [(Z)-2-(5-溴-2-羟基苯亚甲基)苯并呋喃-3(2H)-酮]被鉴定为 SIRT1 的有效抑制剂(IC50=1μM),它可使 p53 的乙酰化呈剂量依赖性增加,从而诱导细胞凋亡。

相似文献

1
Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.乙二胺二乙酸(EDDA)介导的超声条件下奥rone 的合成:作为 SIRT1 抑制剂的评价。
Bioorg Med Chem Lett. 2012 Oct 1;22(19):6160-5. doi: 10.1016/j.bmcl.2012.08.017. Epub 2012 Aug 9.
2
Synthesis, antiproliferative activities and in vitro biological evaluation of novel benzofuransulfonamide derivatives.新型苯并呋喃磺酰胺衍生物的合成、抗增殖活性及体外生物学评价。
Bioorg Med Chem Lett. 2011 Sep 15;21(18):5389-92. doi: 10.1016/j.bmcl.2011.07.007. Epub 2011 Jul 13.
3
HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.HIF-1α 抑制剂:新型麦角甾醇 O 和 P 类似物的合成与生物学评价。
Eur J Med Chem. 2011 Jun;46(6):2386-96. doi: 10.1016/j.ejmech.2011.03.022. Epub 2011 Mar 21.
4
Ultrasound Assisted Synthesis of 2-Substituted Benzofurans via One-Pot and Sequential Method: Their In Vitro Evaluation.超声辅助一锅法和顺序法合成 2-取代苯并呋喃:体外评价。
Anticancer Agents Med Chem. 2020;20(5):580-588. doi: 10.2174/1871520620666200128120356.
5
Antiproliferative potency of novel benzofuran-2-carboxamides on tumour cell lines: cell death mechanisms and determination of crystal structure.新型苯并呋喃-2-甲酰胺类化合物对肿瘤细胞系的抗增殖作用:细胞死亡机制及晶体结构测定。
Eur J Med Chem. 2013 Jan;59:111-9. doi: 10.1016/j.ejmech.2012.11.009. Epub 2012 Nov 16.
6
Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.新型苯并咪唑衍生物作为具有抗肿瘤活性的沉默调节蛋白抑制剂的合成与评价
Bioorg Med Chem. 2014 Jan 15;22(2):703-10. doi: 10.1016/j.bmc.2013.12.029. Epub 2013 Dec 19.
7
Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.苯并呋喃基麦角甾二烯胺类似物的合成及其对非小细胞肺癌细胞系的抗增殖活性。
Eur J Med Chem. 2013 Nov;69:823-32. doi: 10.1016/j.ejmech.2013.09.013. Epub 2013 Sep 18.
8
Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.从筛选命中化合物出发,通过合理的进化设计得到新型强效且选择性的 Moloney 鼠白血病病毒激酶 1(PIM1)抑制剂前病毒整合位点。
J Med Chem. 2012 Jun 14;55(11):5151-64. doi: 10.1021/jm3001289. Epub 2012 May 17.
9
Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.设计、合成和发现 5-羟基色酮衍生物作为抑制 HUVEC 和一些癌细胞系生长的抑制剂。
Eur J Med Chem. 2010 Dec;45(12):5950-7. doi: 10.1016/j.ejmech.2010.09.061. Epub 2010 Oct 7.
10
Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.基于咪唑骨架的 2-苄基苯并呋喃新型杂合化合物的设计、合成及生物评价作为有效的抗癌剂。
Eur J Med Chem. 2013 Apr;62:111-21. doi: 10.1016/j.ejmech.2012.12.040. Epub 2013 Jan 3.

引用本文的文献

1
A novel aurone RNA CAG binder inhibits the huntingtin RNA-protein interaction.一种新型金合欢素RNA CAG结合剂可抑制亨廷顿蛋白RNA-蛋白质相互作用。
RSC Med Chem. 2024 Jul 17;15(9):3092-3096. doi: 10.1039/d4md00403e. eCollection 2024 Sep 19.
2
Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity, and DFT Studies.新型 N-(3-乙炔基苯基)-6,7-双(2-甲氧基乙氧基)喹唑啉-4-胺衍生物:合成、表征、抗癌活性及 DFT 研究。
Anticancer Agents Med Chem. 2024;24(7):514-532. doi: 10.2174/0118715206276286231220055233.
3
An efficient one-pot synthesis and docking studies of bioactive new antiproliferative dispiro[oxindole/acenaphthylenone‒benzofuranone] pyrrolidine scaffolds.
生物活性新型抗增殖双螺[氧化吲哚/萘并菲酮-苯并呋喃酮]吡咯烷支架的高效一锅法合成及对接研究
Mol Divers. 2024 Oct;28(5):3165-3180. doi: 10.1007/s11030-023-10741-4. Epub 2023 Nov 8.
4
Catalyst-Controlled Selectivity Switch in Three-Component Reaction: An NHC-Catalyzed Strategy for the Synthesis of δ-Lactone-Fused Spirobenzofuran-3-ones.催化剂控制的三组分反应选择性开关:一种 NHC 催化的δ-内酯-并色满-3-酮合成策略。
Molecules. 2022 Sep 13;27(18):5952. doi: 10.3390/molecules27185952.
5
Virtual Screening in the Identification of Sirtuins' Activity Modulators.虚拟筛选鉴定 Sirtuins 活性调节剂。
Molecules. 2022 Sep 1;27(17):5641. doi: 10.3390/molecules27175641.
6
Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.基于配体的虚拟筛选与归纳学习用于鉴定天然产物中的SIRT1抑制剂
Sci Rep. 2016 Jan 25;6:19312. doi: 10.1038/srep19312.
7
Sirtuin inhibitors as anticancer agents.沉默调节蛋白抑制剂作为抗癌药物。
Future Med Chem. 2014 May;6(8):945-66. doi: 10.4155/fmc.14.44.